Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |